MedTrace Logo

Refractive Accuracy of Argos in Conjunction With the Alcon Vision Suite Following Implantation of Presbyopia Correcting IOLs

NCT05901597 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2026-02-13

No results posted yet for this study

Summary

The objective is to assess refractive accuracy of the Alcon Vision Suite (with Argos biometer) following Clareon PanOptix and AcrySof Vivity IOL implantation.

Conditions

  • Cataract

Interventions

DEVICE

Clareon PanOptix and AcrySof Vivity IOL implantation Alcon Vision Suite and Argos biometer

Clareon PanOptix and AcrySof Vivity IOL implantation Alcon Vision Suite and Argos biometer

Sponsors & Collaborators

  • Sengi

    collaborator INDUSTRY

  • Valley Laser Eye Centre

    lead OTHER

Principal Investigators

  • John Blaylock, MD · Valley Laser Eye Centre

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-09
Primary Completion
2025-12-02
Completion
2025-12-02
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05901597 on ClinicalTrials.gov